The symbiotic partnership between endoscopists and anesthesiologists could soon be at risk after CMS waived co-payment and deductible responsibilities for colonoscopy patients, according to an Anesthesia Business Consultants' letter.
GI & Endoscopy
Caesarea, Israel-based LifeBond is enrolling patients in the United States and Western Europe for its LifeSeal Surgical Sealant's IDE clinical trial.
Prabhakar Swaroop, MD, a gastroenterologist at Hutchinson (Kan.) Clinic, contributed to Conn's Current Therapy 2017, the McPherson Sentinel reports.
Ismail Wadiwala, MD, is a gastroenterologist at Sutter Tracy (Calif.) Community Hospital.
Tel-Aviv, Israel-based RedHill Biopharma treated the last patient enrolled in its Bekinda's 24 mg phase III clinical trial.
Little Falls, N.J.-based Cantel Medical Corp. agreed to purchase Australia-based distributor CR Kennedy & Co.'s endoscopy business, NJBiz reports.
Gastroenterology-focused companies made headlines this past week for closing on deals and selling assets totaling billions.
Shahab Aftahi, MD, is a gastroenterologist at Goodyear, Ariz.-based Estrella Gastroenterology.
San Francisco-based Versant Ventures debuted Jecure Therapeutics on Feb. 15, 2017.
Researchers presented a study at the American Gastroenterological Association's 2016 conference that claims patients with Barrett's esophagus are more likely to have early stage gastrointestinal cancers beyond the gastroesophageal junction, General Surgery News reports.
